Answers are grounded in this paper and cite their sources.
An early and significant biochemical abnormality in Duchenne's muscular dystrophy is an increase in intracellular calcium. We have found that the "calcium-blocker" drug verapamil inhibits calcium-stimulated efflux of creatine kinase (EC 2.7.3.2) and lactate dehydrogenase (EC 1.1.1.27) in vitro from normal human skeletal muscle at therapeutic concentrations. Such a calcium blocker might therefore be useful in the treatment of Duchenne's muscular dystrophy.
No takes yet. Share an insight, caveat, or question.
Anand et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: